Neurobio

UK-based, preclinical stage biopharma startup developing therapeutics for Alzheimer's disease.

placeOxford, England, United Kingdom calendar_todayFounded 2013 groups10 employees language neuro-bio.com

Registered entities

Social engagement

Social engagement: 2.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

61 investors on record.

Investor typeCountShare
Venture capital12%
Private equity23%
Other / undisclosed5895%

Recent activity

29 Jun 2026
Event
Swansea University FMHLS PGR Conference 2026
20 May 2026
Event
How synthetic binders are transforming diagnostics and molecular biology
Coming soon